ASTRAZENECA PLC 13D and 13G filings for Aridis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-10 10:25 am Unchanged |
2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
ASTRAZENECA PLC | 884,956 3.400% |
0 (Unchanged) |
Filing |
| 2021-07-27 1:20 pm Purchase |
2021-07-20 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
ASTRAZENECA PLC | 884,956 7.300% |
884,956 (New Position) |
Filing |